Necroptosis is a type of regulated cell death that has been implicated in various diseases. Receptor-interacting protein 3 (RIP3), a member of the RIP family, is an important mediator of the necroptotic pathway. Cleavage of RIP3 at Asp328 by caspase-8 abolishes the kinase activity of RIP3, which is critical for necroptosis. Moreover, RIP3 is significantly upregulated during the early stages of acute high intra-ocular pressure and oxygen glucose deprivation. In this study, the effects of RIP3 during elevated hydrostatic pressure (EHP) were investigated and the possible mechanism through which caspase-8 regulated RIP3 cleavage was explored. Flow cytometry analysis revealed that the number of EHP-induced necrotic retinal ganglion cell 5 (RGC-5) cells was reduced after RIP3-knockdown. Furthermore, malondialdehyde (MDA) levels and glycogen phosphorylase (PYGL) activity in normal RGC-5 cells were much higher than those in RIP3-knockdown cells after EHP. EHP-induced RGC-5 necrosis was significantly reduced after treatment with butylated hydroxyanisole (BHA), a reactive oxygen species (ROS) scavenger. MDA levels and PYGL activity were lower in normal RGC-5 cells than those in cells with caspase-8 inhibition after EHP. Western blot analysis demonstrated that the RIP3 cleavage product was upregulated in cells with caspase-8 inhibition. Additionally, flow cytometry analysis revealed that the number of EHPinduced necrotic RGC-5 cells was increased after caspase-8 inhibition. Our results suggested that RGC-5 necroptosis following EHP was mediated by RIP3 through induction of PYGL activity and subsequent ROS accumulation. Thus, caspase-8 may participate in the regulation of RGC-5 necroptosis via RIP3 cleavage.
Introduction
Necroptosis is a form of programmed cell death that is regulated by specific molecules and exhibits morphological features similar to those of necrosis, including plasma integrity loss and organelle swelling. Necroptosis is a caspase-independent form of cell death and involves a variety of molecules [1, 2] . Some researchers have demonstrated the occurrence of necroptosis in various injury-related conditions [3] [4] [5] .
For example, Rosenbaum et al. [6] found necroptotic cells in the retinal ganglion cell (RGC) layer during acute high intra-ocular pressure (aHIOP). Del Olmo-Aguado et al. [7] found that blue light can lead to the death of RGC-5 cells and this effect could be blunted by necrostatin-1. These results implied that necroptosis occurs under irradiation with blue light. Additionally, Xu et al. [8] found that formation of receptor-interacting protein 3 (RIP3)-apoptosis-inducing factor (AIF) complex and its nuclear translocation is critical for programmed necrosis.
Our previous study demonstrated that elevated hydrostatic pressure (EHP) is involved in RGC-5 cell necroptosis. Calpain, a calcium-activated neutral protease that belongs to the family of cytosolic cysteine proteinases [9] , may induce necroptosis via tAIFmodulation in RGC-5 cells following EHP [10] . However, our results showed that necrosis still occurs in RGC-5 cells after inhibition of calpain activity, suggesting that necroptosis may not be completely eliminated after inhibition of calpain activity following EHP. In other words, necroptosis may also be induced by calpain-AIF-independent pathways.
In addition to calpain, some other proteins, including RIP3, Fasassociated protein (FADD)-like interleukin-1β-converting enzymeinhibitory protein (FLIP), HtrA2/Omi, ubiquitin C-terminal hydrolase (UCH-L1), and CDGSH iron sulfur domain 1 (CISD1), have also been shown to participate in cellular necroptosis [11] [12] [13] . RIP3 is considered to be one of the most important molecules involved in necroptosis [8, [10] [11] [12] [13] [14] . Necroptosis can be initiated by engaging with tumor necrosis factor-α (TNF-α) receptor superfamily proteins or FADD when apoptosis signaling is inhibited [15, 16] . Caspase-8 can directly cleave RIP3 to eliminate the kinase domain which is a critical element for inducing necroptosis. Therefore, caspase-8 regulates RIP3-induced necroptosis through cleavage of RIP3 [17, 18] . Additionally, RIP3 may induce upregulation of glycogen phosphorylase (PYGL) and glutamine synthase, causing excessive phosphorylation of glucose and α-ketoglutarate, and subsequently leading to reactive oxygen species (ROS) accumulation, tricarboxylic acid cycle acceleration in the mitochondria, and necrosis [19, 20] . RIP3 may also promote the phosphorylation of mixed lineage kinase domain-like protein (MLKL) to induce cell death [21] [22] [23] . In general, ROSs are important downstream molecules of cell necroptosis induced by various insults [24, 25] .
Our previous study showed that RIP3 could affect RGC death. RIP3 is expressed in RGCs, and RIP3 protein levels are upregulated during the early stages of aHIOP, although the distribution pattern does not change. Thus, our previous findings suggested that RIP3 upregulation may be related to RGC necrosis [26] . Although RIP3 plays an important role in RGC necroptosis following aHIOP [26] , further studies are needed to clarify the regulatory mechanisms of RIP3 function, particularly the involvement of caspase-8. In this study, we demonstrated the effects of RIP3 on necroptosis using RNA interference (RNAi) and identified downstream ROS through metabolic dysregulation. Then the mechanisms through which caspase-8 regulated RIP3 cleavage were evaluated. Our results provide insights into the understanding of the mechanisms of RGC necroptosis in aHIOP-induced retinal diseases and provide experimental evidence to support the potential targeting of this process in future translational medicine application.
Material and Methods

Reagents
Rabbit anti-RIP3 antibodies were obtained from Sigma-Aldrich (St Louis, USA), rabbit anti-RIP3 (C-terminal) antibodies were obtained from LifeSpan BioSciences (LS-C97217; Seattle, USA), rabbit anti-β-tubulin antibodies were obtained from Abcam (Cambridge, UK), and the fluorescein isothiocyanate-Annexin V/propidium iodide (PI) apoptosis assay kit was obtained from Clontech (Mountain View, USA). Morpholino oligonucleotides were synthesized by Gene Tools, LLC (Philomath, USA). Bicinchoninic acid assay reagents were purchased from Pierce (Rockford, USA). The lipid peroxidation malondialdehyde (MDA) kit was obtained from Jian-Cheng Biotechnical Co. (Nanjing, China). The PYGL activity test kit was obtained from Genmed Biotechnology Co. (Shanghai, China). Goat anti-rabbit secondary antibodies were obtained from Jackson Immuno Research Inc. (Lancaster, USA). Z-IETD (a caspase-8 activity-specific inhibitor) and active caspase-8 peptide were obtained from Abcam and butylated hydroxyanisole (BHA) was obtained from Sigma-Aldrich.
Cell culture
Mouse RGC-5 cells were provided by the Department of Ophthalmology, Second Hospital of Jilin University (Changchun, China) [27] . RGC-5 cells were grown in Dulbecco's modified Eagle's medium (DMEM; HyClone Laboratories, Inc., Logan, USA) supplemented with 10% fetal bovine serum (FBS; HyClone Laboratories, Inc.), 100 U/ml penicillin, and 100 μg/ml streptomycin (HyClone Laboratories, Inc.). The cells were grown at 37°C under a humidified atmosphere of 5% CO 2 and were used at 2-3 passages postthawing to minimize variations. The density of RGC-5 cells was around 70% in 6 ml culture medium in a 50-ml flask before EHP.
Immunofluorescence staining
Coverslips with fixed cells were washed in 0.01 M phosphate buffer saline (PBS) for 3 min, blocked with 5% bovine serum albumin (BSA), and then incubated with rabbit anti-RIP3 antibodies (1:200) overnight. Cells were then incubated with Cy3-conjugated donkey anti-rabbit secondary antibodies at a dilution of 1:200 (Invitrogen, Carlsbad, USA) and covered with antifade mounting medium before examination on an Eclipse 80i microscope (Nikon, Tokyo, Japan).
Polymerase chain reaction
Cultured cells were harvested, and RNA was isolated using Trizol reagent (Invitrogen). cDNA was synthesized using Thermoscript (Invitrogen) from 1 μg of total RNA. Specific primer pairs (β-actin forward primer, 5′-CAACTTGATGTATGAAGGCTTTGGT-3′, reverse primer, 5′-ACTTTTATTGGTCTCAAGTCAGTGTACAG-3′; and RIP3 forward primer, 5′-GATTTTGGCCTGTCCACGTT-3′, reverse primer, 5′-CAGGCCCAACTGATGTGTCC-3′) were used for polymerase chain reaction (PCR) amplification. β-Actin was used as the normalization control (CTL). The PCR conditions were as follows: 94°C for 3 min; 36 cycles of 94°C for 45 s, 55°C for 50 s, and 72°C for 2 min; and a final extension at 72°C for 10 min.
Cell injury
A pressurized incubator was designed to expose the cells to an EHP, as described in our previous study [10] . After 2 h of exposure in this pressure system, with a pressure of 100 mMHg, cells were then moved to a conventional culture incubator to recover for different lengths of time (6, 12 , and 24 h). Z-IETD was dissolved in dimethyl sulfoxide at a concentration of 10 mM for storage, and cells were pretreated with 10 μM Z-IETD for 12 h before cell injury. Active caspase-8 peptide was added to DMEM directly before cell injury for 12 h at a concentration of 1.5 U/ml.
Western blot analysis
At each survival time point, cells were homogenized on ice in digestion buffer [150 mM NaCl, 25 mM Tris-HCl (pH 7.4), 2 mM ethylenediaminetetraacetic acid, 1.0% Triton X-100, 1.0% sodium deoxycholate, and 0.1% sodium dodecyl sulfate (SDS)] containing a cocktail of protease inhibitors (Sigma-Aldrich). The homogenates were then centrifuged at 10,000 g for 20 min at 4°C. The supernatants were collected, and the protein concentration was determined using a bicinchoninic acid assay kit (Beyotime biotechnology, Shanghai, China). A total of 50-100 μg protein in 62.5 mM Tris loading buffer (pH 6.8, containing 25% glycerol, 2% SDS, 0.01% bromophenol blue, and 5% β-mercaptoethanol; Bio-Rad, Berkeley, USA) was boiled for 5 min, separated by SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes (Bio-Rad). Nonspecific binding was blocked with PBS containing 5% nonfat milk (Bio-Rad) and 3% BSA for 1 h. Membranes were incubated with anti-RIP3 (full-length, 1:200; C-terminal, 1:500) or anti-β-tubulin (1:1000) antibodies overnight, washed and subsequently incubated with horseradish peroxidaseconjugated secondary antibodies (1:20,000; Bio-Rad) for 2 h. Immunoblotting products were visualized with an ECL Plus Western Blotting Detection kit (GE Healthcare Life Sciences, Piscataway, USA) according to the manufacturer's instructions, and images were captured using a Molecular Dynamics Phosphorimager (Nucleo Tech Inc., San Mateo, USA). Western blots were measured with Image J (National Institutes of Health, Bethesda, USA) to analyze the integrated density value (IDV). The average IDVs of RIP3 and β-tubulin were compared, and the average relative value was obtained. Each experiment was repeated at least three times.
Flow cytometry
Cells attached to flasks were trypsinized and washed gently. Cells were then resuspended in 200 μl of 1× binding buffer, after which 5 μl of 20 μg/ml AnnexinV and 10 μl of 50 mg/ml PI were added to the suspension. Cells were then incubated at 25°C for 15 min in the dark, washed, and analyzed using a FACSCalibur instrument (Becton Dickinson Company, Franklin Lakes, USA). The percentages of cells in each quadrant were analyzed using ModFit software (Verity Software House, Topsham, USA). Statistical analyses of flow cytometry results were conducted by calculating the number of PIpositive cells. All analyses were repeated three times.
Knockdown of RIP3 expression using antisense morpholinos
The expression of RIP3 was inhibited using antisense morpholino oligos according to the method described by Garlapati [28] . The RIP3 morpholino oligo and standard CTL oligo was designed and purchased from Gene Tools LLC. The RIP3 morpholino oligo used for inhibition of RIP3 translation had the following sequence: 5′-AGGCCAT AACTTGACAGAAGACATC-3′. The standard CTL oligo sequence was as follows: 5′-CCTCTTACCTCAGTTACAATTTATA-3′. When the density of RGC-5 cells was around 80%, the cells were incubated with 1 μM RIP3 morpholino oligo for 48 h.
Caspase-8 activity assays
At each survival time point, cells were digested by sonication on ice in digestion buffer containing a cocktail of protease inhibitors. The homogenates were then centrifuged at 10,000 g for 20 min at 4°C. Caspase-8 activity levels in RGC-5 extracts were assayed using a commercial kit according to the manufacturer's instruction. Equal amounts (100 μg) of supernatant were loaded in each well, and each analysis was performed in triplicate.
PYGL activity assays
PYGL is an enzyme involved in the first step of glucose utilization, and the activity of this enzyme can represent the level of glycolysis. At each survival time point, cells were digested by sonication on ice in digestion buffer containing a cocktail of protease inhibitors. The homogenates were then centrifuged at 10,000 g for 20 min at 4°C. PYGL activity levels in RGC-5 extracts were assayed using a commercial kit according to the manufacturer's instructions. Equal amounts (100 μg) of supernatant were loaded in each well, and each analysis was performed in triplicate.
MDA concentration assay
MDA is a lipid peroxidation marker that reflects ROS levels in cells. At each survival time point, cells were digested by sonication on ice in digestion buffer containing a cocktail of protease inhibitors. The homogenates were then centrifuged at 10,000 g for 20 min at 4°C. MDA levels in RGC-5 extracts were assayed using a commercial kit according to the manufacturer's instructions, as described in our previous study [29] . Equal amounts (100 μg) of supernatant were loaded in each well, and each analysis was performed in triplicate.
ROS inhibition assay
BHA is an antioxidant consisting of a mixture of two isomeric organic compounds, 2-tert-butyl-4-hydroxyanisole and 3-tert-butyl-4-hydroxyanisole, which are ROS scavengers. BHA was dissolved in ethanol, and cells were pretreated with 30 μM BHA for 1 h before EHP. At the 12 h survival time point, lactate dehydrogenase (LDH) assay was carried out to detect the ratio of necrosis.
LDH release assay
LDH assays are non-radioactive colorimetric assays that measure LDH release from necrotic cells into the extracellular space/supernatant upon rupture of the plasma membrane [30] . The LDH release rate was determined using an LDH cytotoxicity assay kit (Beyotime, Haimen, China) after treatment. Cell-free culture supernatants were collected from each well and incubated with the appropriate reagent mixture according to the manufacturer's instructions at room temperature for 30 min. The intensity of the red color formed in the assay, measured at a wavelength of 490 nm, was proportional to both LDH activity and the percentage of necrotic cells. Total LDH release was determined in cell cultures treated with LDH-releasing reagent from the assay kit. The percentage of necrotic cell death was calculated based on the color intensity of treated cells minus CTL cells divided by that of LDH-releasing reagent-treated cells minus CTL cells from four independent experiments.
Statistical analysis
One-way analysis of variance was performed to test differences in average values between groups. All results are presented as the mean ± standard deviations. Differences with P-values of <0.05 were considered statistically significant. The data were analyzed by using SPSS 19.0 (SPSS Inc., Chicago, USA).
Results
RIP3 protein was upregulated following EHP
Immunofluorescence staining showed that RIP3 was mainly present in the cytoplasm of RGC-5 cells under normal conditions (Fig. 1A) . The results of western blot analysis showed that RIP3 was present as a single band in all groups (Fig. 1B) . The RIP3-positive signal band in the 12 h EHP group was significantly stronger than that in the CTL group, while the bands in 6 and 24 h EHP groups were thinner and smaller than those in the 12 h EHP group, similar to that in the CTL. Statistical analysis of IDVs indicated that high pressure stimulated the upregulation of RIP3 protein at the early stage (Fig. 1C) , and significantly more distinct RIP3 bands were observed in the 12 h EHP group. These results demonstrated that the protein levels of RIP3 initially increased and then decreased over time within 1 day, reaching a maximum at 12 h.
RIP3 protein levels in RIP3-knockdown RGC-5 cells following EHP
Compared with normal RGC-5 cells and RGC-5 cells transfected with standard CTL oligos, RIP3 protein levels were decreased in RIP3-knockdown cells (Fig. 2A) . The IDVs differed significantly among groups (Fig. 2B) . A similar tendency was observed for RIP3 messenger RNA (mRNA) (Fig. 2C,D) . These results indicated that RIP3-knockdown RGC-5 cells were successfully constructed.
RIP3 bands in the RIP3-knockdown group at 12 h following EHP were thinner and smaller than those in the EHP groups (Fig. 2E) . Statistical analysis of IDVs indicated that high pressure increased the expression of RIP3 during the early stages (Fig. 2F) and that significantly smaller RIP3 bands were observed in the 12 h injury group after transfection with RIP3 RNAi. Thus, these data demonstrated that RIP3 expression was decreased following EHP after transfection with RIP3 RNAi, with a greater reduction observed in the 12 h group.
PYGL activity and MDA levels were decreased in RIP3-knockdown RGC-5 cells following EHP PYGL activity assays and MDA assays were performed at 2 h after EHP. Both PYGL activity and MDA levels in the EHP model group and RGC-5 RIP3-knockdown group were significantly increased compared with those in the CTL group, reaching a maximum at 12 h. However, PYGL activity and MDA levels in the RIP3-knockdown EHP group were significantly decreased compared with those in the normal EHP model group (Fig. 3) .
EHP-induced RGC-5 cell necroptosis was mediated by RIP3
Flow cytometry with PI/Annexin V double staining of RIP3-knockdown and normal RGC-5 cells was used to determine the involvement of RIP3 in EHP-induced necroptosis after a 12 h recovery. The results demonstrated that there were more necrotic cells in both the EHP and RIP3-knockdown groups than those in the CTL group (Fig. 4A-C) . However, the number of PI-positive cells in the RIP3-knockdown group was significantly decreased compared with that in the EHP group (Fig. 4D) . Detection of necrotic cells using LDH release assays indicated that RIP3-knockdown may protect RGC-5 cells from necrosis following EHP (Fig. 4E) . Finally, we detect necrotic cells using LDH release assays after BHA treatment and found that necrotic cells decreased from 14.2% to 9.1%, indicating that BHA may have blocked RGC-5 cell necrosis following EHP (Fig. 4F) .
RIP3 protein levels were upregulated in the 24 h group with Z-IETD treatment and downregulated in the presence of active caspase-8 following EHP
Next, RIP3 protein levels were investigated using an antibody recognizing the C-terminal of RIP3 to determine levels of the cleavage product of RIP3. The results showed a~30 kDa band representing the cleavage product in all groups (Fig. 5A) . The cleavage product band in the active caspase-8 groups after EHP was obviously thicker and larger than those of EHP groups at 24 h. The cleavage product band in the Z-IETD group was thinner and smaller than those in the EHP groups. Statistical analysis of IDVs indicated that high pressure increased the levels of cleaved RIP3 during the early stage (Fig. 5B) . Moreover, a significant reduction in the RIP3 cleavage product was observed in the Z-IETD group, and increased levels of the RIP3 cleavage product were observed in the active caspase-8 group. The RIP3 cleavage product of Z-IETD single treatment group was significantly lower than that of EHP-Z-IETD group. Thus, these findings demonstrated that RIP3 was cleaved by caspase-8 at 24 h after EHP. Then, the activity of caspase-8 was measured under different treatment conditions. Caspase-8 activity levels were detected at 2 h after EHP and at different time intervals after recovery under normal conditions. In the EHP group, caspase-8 activity levels were gradually increased compared with those in the normal CTL group, peaked at 24 h (P < 0.05 versus all groups; Fig. 5C ). Moreover, in the EHP, Z-IETD, and active caspase-8 groups, caspase-8 activity levels were significantly increased compared with those in the CTL group, with the highest levels observed in the active caspase-8 group (P < 0.05). However, the level of caspase-8 activity in the Z-IETD group was decreased significantly compared with that in the EHP group at 24 h, and caspase-8 activity was slightly decreased with Z-IETD treatment (Fig. 5D) .
MDA levels and PYGL activity at 24 h after EHP in cells treated with Z-IETD and active caspase-8
MDA and PYGL activity assays showed that MDA levels and PYGL activity were significantly increased at 2 h following EHP and after a 24 h recovery under normal conditions in the EHP, EHP-Z-IETD, and EHP-active caspase-8 groups as compared with those in the CTL and Z-IETD single treatment groups, with the highest levels detected in the EHP-Z-IETD group. However, PYGL activity and MDA levels were significantly lower in the active caspase-8 group than those in the normal EHP group. PYGL activity and MDA levels of Z-IETD single treatment group were significantly lower than those in the EHP-Z-IETD group (Fig. 6) .
RIP3-mediated RGC-5 cell necrosis was regulated by caspase-8
Flow cytometry with PI/Annexin V double staining in RGC-5 cells treated with Z-IETD or active caspase-8 was adopted to determine the regulatory role of caspase-8 in RIP3-mediated necroptosis after a 24 h recovery. The results showed that there were more necrotic cells in the normal EHP group, EHP-Z-IETD group, and active caspase-8 group than in the CTL group (Fig. 7A-D) . Notably, the ratio of necrosis did not differ between the Z-IETD single treatment group and CTL group (Fig. 7A,B) ; however, the number of PIpositive cells in the active caspase-8 group was significantly decreased (Fig. 7E) , whereas that in the EHP-Z-IETD group was significantly increased (Fig. 7D ) compared with that in the normal EHP group (Fig. 7C) . The necrotic cells of Z-IETD single treatment group were significantly lower than those of EHP-Z-IETD group (Fig. 7F) . Necrotic cells were also detected by LDH release assays ( Fig. 7G) . These results suggested that necrosis may be reduced when RIP3 was cleaved by caspase-8.
Discussion
Several different proteins, including RIPs, HtrA2/Omi, UCH-L1, CISD1, and calpain, have been shown to regulate necroptosis. Among these molecular pathways, the RIP pathway was the first pathways shown to mediate necroptosis, and many studies have investigated the mechanisms in great detail [31, 32] . When apoptosis signals are inhibited, RIP3 binds to RIP1 to form a complex through the RIP homotypic interaction motif, which further phosphorylates RIP3 to mediate necroptosis [33] . The phosphorylation of RIP3 could activate RIP1 to promote the activation of key enzymes in glycolysis. Finally, increased levels of ROS may be produced, thereby promoting necroptosis [34] .
Recent studies have shown that necroptosis is not initiated in RIP3-knockout cells when TNF-α mediated apoptosis is blocked by Z-VAD. These findings suggest that RIP3 may be an important target in cellular necroptosis. Moreover, RIP3 expression levels have been shown to be increased in secondary neural tissue damage following spinal cord injury without Z-VAD [35] . Additionally, our previous study also demonstrateded that RIP3 was significantly upregulated in the rat retina during the early stages after induction with high intra-ocular pressure. However, whether RIP3 participates in RGC-5 cell necroptosis following EHP remains unknown. The protein level of RIP3 in RGC-5 cells was significantly upregulated following a 2-h insult and recovery under normal conditions for 12 h. When RIP3 expression was interfered, the ratio of necrosis was significantly decreased compared with that in the EHP group, suggesting that RIP3 might play a key role in RGC-5 cell necroptosis following EHP. Our results also showed that MDA concentrations and PYGL activities were increased after EHP and were significantly decreased in RIP3-knockdown cells compared with those in wildtype cells. Moreover, EHP-induced RGC-5 cell necrosis was significantly reduced after BHA treatment, similar to the results of studies by Shindo et al. and Simenc et al. [24, 25] . Collectively, these data suggested that a pathway involving RIP3/PYGL/ROS signaling may be related to EHP-induced necroptosis. Liu et al. [36] reported that oxidative stress products may lead to necroptosis in hippocampal neurons. Gao et al. [37] also found that the necroptotic cell death mechanism is executed through a pathway involving extracellular signal-regulated kinase 1/2 (ERK1/2) and RIP3 in RGCs during early stages after ischemia-reperfusion. Our results provide further insights into the mechanisms of necroptosis in RGCs. We further demonstrated that RIP3 was involved in necroptosis in RGC-5 cells after EHP. However, flow cytometry results demonstrated that necrosis was not eliminated after RIP3-knockdown, and MDA levels and PYGL activities were still higher than those in the CTL group. This could be explained by the observation that some of the RGC-5 cells still underwent necrosis and that RIP3 protein levels could not be completely downregulated using morpholino oligos. We also found that the RIP3 molecular pathway was not the only mechanism mediating necroptosis. In our previous study, we showed that calpain, a calcium-activated neutral protease, may induce necroptosis via tAIF-modulation in RGC-5 cells following EHP, suggesting that there are at least two molecular pathways participating in EHP-induced necroptosis in RGC-5 cells.
Caspase-8 belongs to a family of cysteine-aspartic acid proteases (caspases) and is encoded by the CASP8 gene [38] . This caspase is thought to act on caspase-3, and previous studies have shown that sequential activation of caspases plays a central role in the execution phase of apoptosis. However, some studies have revealed that caspase-8 may participate in regulating necroptosis. Caspase-8 could cleave RIP3 at Asp328 [39] , and the cleaved form of RIP3 did not contain the kinase domain to mediate necroptosis. Thus, caspase-8 is a key molecule regulating RIP3-mediated necroptosis. Our results showed that the activity of caspase-8 was significantly increased during the early stages of EHP. However, whether caspase-8 regulates RIP3-mediated necroptosis induced by EHP still remains unknown. Western blot analysis showed that cleaved RIP3 was significantly increased in the Z-IETD group and decreased in the active caspase-8 group compared with that in the model group, suggesting that caspase-8 could cleave full-length of RIP3 and cause loss of C-terminal activity, thereby leading to decreased RIP3-mediated necroptosis. Hence, we propose that decreased levels of the C-terminal part of RIP3 protein may be related to caspase-8 cleavage of full-length of RIP3. The results of flow cytometry also showed that the ratio of necrosis was increased in the Z-IETD group compared with that in the model group, but was decreased in the caspase-8 active group. These results suggested that caspase-8 may be an important regulator of necroptosis. Our further analyses showed that MDA levels and PYGL activities were significantly different in the Z-IETD and active caspase-8 groups, consistent with the findings of RIP3 (C-terminal) protein expression. Based on the results of flow cytometry and LDH assays, we speculated that if the expression of the C-terminal of RIP3 decreases, MDA levels and PYGL activity will also decrease and the level of necroptosis may be inhibited. Additionally, caspase-8 may cleave full-length RIP3 to the inactive form, thereby regulating the level of necroptosis in RGC-5 cells following EHP.
Changes in the activity of caspase-8 were found to participate in RIP3-mediated necroptosis in RGC-5 cells following EHP; however, the results of flow cytometry showed that RGC-5 cell necrosis could not be eliminated completely via changes in caspase-8 activity. Our results suggested that caspase-8 could regulate RIP3-mediated necroptosis. Interestingly, some other studies have also reported regulators of RIP3-mediated necroptosis. For example, Liu et al. [40] reported that miR-155 could prevent necroptosis in human cardiomyocyte progenitor cells by directly targeting RIP1 to influence the RIP3 pathway. Besides the reasons discussed above, some necrotic cells may not be regulated by some other mechanisms exclude RIP3 pathway, which could explain our observations. Additional studies are needed to fully elucidate these mechanisms.
In this study, we have found that RGC-5 necroptosis following by EHP was mediated by RIP3 through elevated PYGL activity and subsequent make ROS accumulation. Moreover, caspase-8 may participate in the regulation of RGC-5 necroptosis via RIP3 cleavage.
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